Ascending cholangitis diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
 
Line 4: Line 4:
{{CMG}}; {{AE}} {{AHS}}
{{CMG}}; {{AE}} {{AHS}}
== Overview ==
== Overview ==
MRCP is the diagnostic study of choice for identifying lesions of the biliary tree with sensitivity comparable to that of [[endoscopic retrograde cholangiopancreaticography (ERCP)]]. However, [[Endoscopic retrograde cholangiopancreatography|ERCP]] is the gold standard test in diagnosis of ascending cholangitis and is the test of choice for patients who may need therapeutic drainage
[[MRCP]] is the diagnostic study of choice for identifying lesions of the biliary tree with sensitivity comparable to that of [[ERCP|endoscopic retrograde cholangiopancreaticography (ERCP)]]. However, [[Endoscopic retrograde cholangiopancreatography|ERCP]] is the gold standard test in diagnosis of ascending cholangitis and is the test of choice for patients who may need therapeutic drainage


== Diagnostic Study of Choice ==
== Diagnostic Study of Choice ==


=== Study of choice ===
=== Study of choice ===
'''Magnetic resonance cholangiopancreatography (MRCP)'''  
'''[[MRCP|Magnetic resonance cholangiopancreatography (MRCP)]]'''  
* It is the diagnostic study of choice for identifying lesions of the biliary tree with sensitivity comparable to that of endoscopic retrograde cholangiopancreaticography (ERCP).
* It is the diagnostic study of choice for identifying lesions of the biliary tree with sensitivity comparable to that of [[ERCP|endoscopic retrograde cholangiopancreaticography (ERCP)]].
'''Endoscopic retrograde cholangiopancreatography (ERCP''')<ref name="pmid29226107">{{cite journal| author=Mohammad Alizadeh AH| title=Cholangitis: Diagnosis, Treatment and Prognosis. | journal=J Clin Transl Hepatol | year= 2017 | volume= 5 | issue= 4 | pages= 404-413 | pmid=29226107 | doi=10.14218/JCTH.2017.00028 | pmc=5719198 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29226107  }}</ref>:
[[ERCP|'''Endoscopic retrograde cholangiopancreatography (ERCP''')]]:<ref name="pmid29226107">{{cite journal| author=Mohammad Alizadeh AH| title=Cholangitis: Diagnosis, Treatment and Prognosis. | journal=J Clin Transl Hepatol | year= 2017 | volume= 5 | issue= 4 | pages= 404-413 | pmid=29226107 | doi=10.14218/JCTH.2017.00028 | pmc=5719198 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29226107  }}</ref>
*ERCP is a gold standard test in diagnosis of ascending cholangitis<ref name="pmid181915233">{{cite journal| author=Lee NK, Kim S, Lee JW, Kim CW, Kim GH, Kang DH et al.| title=Discrimination of suppurative cholangitis from nonsuppurative cholangitis with computed tomography (CT). | journal=Eur J Radiol | year= 2009 | volume= 69 | issue= 3 | pages= 528-35 | pmid=18191523 | doi=10.1016/j.ejrad.2007.11.031 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18191523  }}</ref>
*[[ERCP]] is a gold standard test in diagnosis of ascending cholangitis<ref name="pmid181915233">{{cite journal| author=Lee NK, Kim S, Lee JW, Kim CW, Kim GH, Kang DH et al.| title=Discrimination of suppurative cholangitis from nonsuppurative cholangitis with computed tomography (CT). | journal=Eur J Radiol | year= 2009 | volume= 69 | issue= 3 | pages= 528-35 | pmid=18191523 | doi=10.1016/j.ejrad.2007.11.031 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18191523  }}</ref>
* ERCP is a procedure to examine the pancreatic and bile ducts.
* [[ERCP]] is a procedure to examine the pancreatic and bile ducts
* Direct observation of obstruction or bile duct stone is possible
* Direct observation of obstruction or bile duct stone is possible
* Test of choice for patients who may need drainage
* Test of choice for patients who may need drainage
Line 20: Line 20:
* Can also be used as reference test to determine the efficacy of other methods like [[Magnetic resonance cholangiopancreatography|MRCP]]
* Can also be used as reference test to determine the efficacy of other methods like [[Magnetic resonance cholangiopancreatography|MRCP]]
* Preferred as a therapeutic method for biliary drainage usually as compared to diagnostic
* Preferred as a therapeutic method for biliary drainage usually as compared to diagnostic
* ERCP has a higher rate of complications as compared to other endoscopic procedures. Some common complications include bleeding, trauma, [[pancreatitis]]
* [[ERCP]] has a higher rate of complications as compared to other endoscopic procedures. Some common complications include bleeding, trauma, [[pancreatitis]]


=== TG-13 diagnostic criteria for acute cholangitis<ref name="pmid22825491">{{cite journal| author=Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA et al.| title=New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. | journal=J Hepatobiliary Pancreat Sci | year= 2012 | volume= 19 | issue= 5 | pages= 548-56 | pmid=22825491 | doi=10.1007/s00534-012-0537-3 | pmc=3429782 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22825491  }}</ref> ===
=== TG-13 diagnostic criteria for acute cholangitis<ref name="pmid22825491">{{cite journal| author=Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA et al.| title=New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. | journal=J Hepatobiliary Pancreat Sci | year= 2012 | volume= 19 | issue= 5 | pages= 548-56 | pmid=22825491 | doi=10.1007/s00534-012-0537-3 | pmc=3429782 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22825491  }}</ref> ===

Latest revision as of 23:06, 15 October 2018

Ascending cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Ascending cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ascending cholangitis diagnostic study of choice On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ascending cholangitis diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ascending cholangitis diagnostic study of choice

CDC on Ascending cholangitis diagnostic study of choice

Ascending cholangitis diagnostic study of choice in the news

Blogs on Ascending cholangitis diagnostic study of choice

Directions to Hospitals Treating Ascending cholangitis

Risk calculators and risk factors for Ascending cholangitis diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2]

Overview

MRCP is the diagnostic study of choice for identifying lesions of the biliary tree with sensitivity comparable to that of endoscopic retrograde cholangiopancreaticography (ERCP). However, ERCP is the gold standard test in diagnosis of ascending cholangitis and is the test of choice for patients who may need therapeutic drainage

Diagnostic Study of Choice

Study of choice

Magnetic resonance cholangiopancreatography (MRCP)

Endoscopic retrograde cholangiopancreatography (ERCP):[1]

  • ERCP is a gold standard test in diagnosis of ascending cholangitis[2]
  • ERCP is a procedure to examine the pancreatic and bile ducts
  • Direct observation of obstruction or bile duct stone is possible
  • Test of choice for patients who may need drainage
  • Also done directly in a patient with classic traid of acute cholangitis (fever, jaundice, abdominal pain)
  • Has both diagnostic and therapeutic efficacy
  • Can also be used as reference test to determine the efficacy of other methods like MRCP
  • Preferred as a therapeutic method for biliary drainage usually as compared to diagnostic
  • ERCP has a higher rate of complications as compared to other endoscopic procedures. Some common complications include bleeding, trauma, pancreatitis

TG-13 diagnostic criteria for acute cholangitis[3]

Description
A=Systemic Inflammation A1 Fever >38C and/or Chills
A2 Laboratory evidence of inflammatory response

WBC <4000 or >10,000/uL

CRP more than or equal to 1mg/dl

B=Cholestasis B1 Jaundice - Total bilirubin more than or equal to 2mg/dl
B2 Abnormal liver function tests

ALP - More than 1.5 times upper limit of normal

AST - More than 1.5 times upper limit of normal

ALT - More than 1.5 times upper limit of normal

GGT - More than 1.5 times upper limit of normal

C= Imaging C1 Biliary dilation
C2 Evidence of etiology on the imaging

(stricture, stone, stent)

SUSPECTED DIAGNOSIS - One item in A + one item in either B or C

DEFINITE DIAGNOSIS - One item in A, one item in B and one item in C

References

  1. Mohammad Alizadeh AH (2017). "Cholangitis: Diagnosis, Treatment and Prognosis". J Clin Transl Hepatol. 5 (4): 404–413. doi:10.14218/JCTH.2017.00028. PMC 5719198. PMID 29226107.
  2. Lee NK, Kim S, Lee JW, Kim CW, Kim GH, Kang DH; et al. (2009). "Discrimination of suppurative cholangitis from nonsuppurative cholangitis with computed tomography (CT)". Eur J Radiol. 69 (3): 528–35. doi:10.1016/j.ejrad.2007.11.031. PMID 18191523.
  3. Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA; et al. (2012). "New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines". J Hepatobiliary Pancreat Sci. 19 (5): 548–56. doi:10.1007/s00534-012-0537-3. PMC 3429782. PMID 22825491.

Template:WH Template:WS